keyword
https://read.qxmd.com/read/38282258/what-to-do-after-smoking-relapse-a-sequential-multiple-assignment-randomized-trial-of-chronic-care-smoking-treatments
#21
JOURNAL ARTICLE
Tanya R Schlam, Timothy B Baker, Megan E Piper, Jessica W Cook, Stevens S Smith, Deejay Zwaga, Douglas E Jorenby, Daniel Almirall, Daniel M Bolt, Linda M Collins, Robin Mermelstein, Michael C Fiore
AIM: To compare effects of three post-relapse interventions on smoking abstinence. DESIGN: Sequential three-phase multiple assignment randomized trial (SMART). SETTING: Eighteen Wisconsin, USA, primary care clinics. PARTICIPANTS: A total of 1154 primary care patients (53.6% women, 81.2% White) interested in quitting smoking enrolled from 2015 to 2019; 582 relapsed and were randomized to relapse recovery treatment. INTERVENTIONS: In phase 1, patients received cessation counseling and 8 weeks nicotine patch...
January 28, 2024: Addiction
https://read.qxmd.com/read/38233142/neuronal-excitability-in-the-medial-habenula-and-ventral-tegmental-area-is-differentially-modulated-by-nicotine-dosage-and-menthol-in-a-sex-specific-manner
#22
JOURNAL ARTICLE
Nathan A Olszewski, Samuel Tetteh-Quarshie, Brandon J Henderson
The medial habenula (MHb) has been identified as the limiting factor for nicotine intake and facilitating nicotine withdrawal. However, few studies have assessed MHb neuronal excitability in response to nicotine and, currently, a gap in knowledge is present for finding behavioral correlates to neuronal excitability in the region. Moreover, no study to date has evaluated sex or nicotine dosage as factors of excitability in the MHb. Here, we utilized an e-vape® self-administration (EVSA) model to determine differences between sexes with different nicotine dosages ± menthol...
January 17, 2024: ENeuro
https://read.qxmd.com/read/38229538/safety-of-e-cigarettes-and-nicotine-patches-as-stop-smoking-aids-in-pregnancy-secondary-analysis-of-the-pregnancy-trial-of-e-cigarettes-and-patches-prep-randomized-controlled-trial
#23
JOURNAL ARTICLE
Francesca Pesola, Katie Myers Smith, Anna Phillips-Waller, Dunja Przulj, Christopher Griffiths, Robert Walton, Hayden McRobbie, Tim Coleman, Sarah Lewis, Rachel Whitemore, Miranda Clark, Michael Ussher, Lesley Sinclair, Emily Seager, Sue Cooper, Linda Bauld, Felix Naughton, Peter Sasieni, Isaac Manyonda, Peter Hajek
AIMS: The aim of this study was to examine the safety of e-cigarettes (EC) and nicotine patches (NRT) when used to help pregnant smokers quit. DESIGN: A recent trial of EC versus NRT reported safety outcomes in the randomized arms. We conducted a further analysis based on product use. SETTING: Twenty-three hospitals in England and a stop-smoking service in Scotland took part. PARTICIPANTS: The participants comprised 1140 pregnant smokers...
January 17, 2024: Addiction
https://read.qxmd.com/read/38160877/type-switching-of-short-acting-nicotine-replacement-therapy-products-and-its-implications-for-treatment
#24
JOURNAL ARTICLE
Scott Veldhuizen, Laurie Zawertailo, Peter Selby
INTRODUCTION: The frequency with which people change from one medical treatment to another partly reflects satisfaction with the initial intervention. In this secondary analysis of observational data, we explore switch rates for short-acting nicotine replacement therapy (NRT) products, which differ in mode of use, rapidity of action, and adverse effect profiles. METHODS: We analyzed data from 46,882 participants in the Smoking Treatment for Ontario Patients program who received short-acting NRT (gum, lozenge, oral spray, or inhaler) at their initial visit...
December 29, 2023: J Subst Use Addict Treat
https://read.qxmd.com/read/38159871/competitive-inhibition-of-nicotine-acetylcholine-receptors-using-microneedles-of-nicotine-and-varenicline-for-smoking-withdrawal-therapy
#25
JOURNAL ARTICLE
Ashwini Wani, Bala Prabhakar, Pravin Shende
Current strategies for smoking withdrawal conditions involve monotherapy of nicotine and combinational therapy of nicotine with varenicline or bupropion as per the CDC and FDA. The available dosage forms for nicotine are patches, gums, inhalers and nasal sprays, bupropion and varenicline are available in tablet form. This research work focused on developing a microneedle delivery system to deliver combination drug for overcoming the obstacles encountered by oral route of administration of varenicline such as severe side effects (mood swings, agitation, depressed behaviour, seizures, etc), and nicotine therapy challenges such as short half-life, repeated dosing, nausea, and vomiting...
December 28, 2023: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38139792/the-anti-nociceptive-effects-of-nicotine-in-humans-a-systematic-review-and-meta-analysis
#26
REVIEW
Yujia Luo, Yating Yang, Carl Schneider, Thomas Balle
BACKGROUND: Pain can have a serious impact on a patient's physical, mental, and social health, often causing their quality of life to decline. Various nicotine dosage forms, such as nicotine patches and nasal spray, have been developed and used as analgesics in clinical settings. However, there is controversy over the anti-nociceptive effects of nicotine among different clinical trials. The purpose of this meta-analysis is to quantify the analgesic effect of nicotine patches, nicotine nasal spray, and tobacco smoking on pain in humans...
November 30, 2023: Pharmaceuticals
https://read.qxmd.com/read/38095239/dental-staff-and-patient-attitudes-about-nicotine-replacement-therapy-samples-in-dental-care-a-national-dental-practice-based-research-network-study
#27
JOURNAL ARTICLE
Sandra J Japuntich, Michael S Dunbar, Zachary Predmore, Erika Litvin Bloom, Pearl Fang, Sarah Basile, D Brad Rindal, Lisa A Waiwaiole, Matthew J Carpenter, Dorota T Kopycka-Kedzierawski, Jennifer Dahne, Tamara R Lischka, Peggy Richardson
OBJECTIVES: Cigarette smoking negatively affects oral health. Nicotine replacement therapies (NRT; e.g. nicotine patch or lozenge) and brief interventions (e.g. Ask-Advise-Refer; AAR) can improve cessation outcomes but are underutilized. NRT sampling (NRTS) increases NRT utilization by providing patients with samples of NRT as part of routine healthcare. Ask-Advise-Refer is a brief intervention where practitioners: ask patients about tobacco use, advise those using tobacco to quit and refer to the state quit line...
December 14, 2023: Community Dentistry and Oral Epidemiology
https://read.qxmd.com/read/38060844/reverse-iontophoresis-noninvasive-assessment-of-topical-drug-bioavailability
#28
JOURNAL ARTICLE
Kieran Moore, Sébastien Grégoire, Joan Eilstein, M Begoña Delgado-Charro, Richard H Guy
Assessing drug disposition in the skin after the application of a topical formulation is difficult. It is hypothesized that reverse iontophoresis (RI), which can extract charged/polar molecules for monitoring purposes, may provide a noninvasive approach for the assessment of local drug bioavailability. The passive and RI extraction of salicylic acid (SA) and nicotine (NIC) from porcine skin in vitro was assessed after a simple solution of the former and a transdermal patch of the latter had been applied for 24 and 8 h, respectively...
December 7, 2023: Molecular Pharmaceutics
https://read.qxmd.com/read/38045290/chronic-nicotine-exposure-is-associated-with-electrophysiological-and-sympathetic-remodeling-in-the-intact-rabbit-heart
#29
Amanda Guevara, Charlotte E R Smith, Jessica L Caldwell, Lena Ngo, Lilian R Mott, I-Ju Lee, Inivas Tapa, Zhen Wang, Lianguo Wang, William R Woodward, G Andre Ng, Beth A Habecker, Crystal M Ripplinger
UNLABELLED: Nicotine is the primary addictive component in tobacco products. Through its actions on the heart and autonomic nervous system, nicotine exposure is associated with electrophysiological changes and increased arrhythmia susceptibility. However, the underlying mechanisms are unclear. To address this, we treated rabbits with transdermal nicotine (NIC, 21 mg/day) or control (CT) patches for 28 days prior to performing dual optical mapping of transmembrane potential (RH237) and intracellular Ca 2+ (Rhod-2 AM) in isolated hearts with intact sympathetic innervation...
November 23, 2023: bioRxiv
https://read.qxmd.com/read/38014247/dorsal-motor-vagal-neurons-can-elicit-bradycardia-and-reduce-anxiety-like-behavior
#30
Misty M Strain, Nicholas J Conley, Lily S Kauffman, Liliana Espinoza, Stephanie Fedorchak, Patricia Castro Martinez, Maisie E Crook, Maira Jalil, Georgia E Hodes, Stephen B G Abbott, Ali D Güler, John N Campbell, Carie R Boychuk
Cardiovagal neurons (CVNs) innervate cardiac ganglia through the vagus nerve to control cardiac function. Although the cardioinhibitory role of CVNs in nucleus ambiguus (CVN NA ) is well established, the nature and functionality of CVNs in dorsal motor nucleus of the vagus (CVN DMV ) is less clear. We therefore aimed to characterize CVN DMV anatomically, physiologically, and functionally. Optogenetically activating cholinergic DMV neurons resulted in robust bradycardia through peripheral muscarinic (parasympathetic) and nicotinic (ganglionic) acetylcholine receptors, but not beta-1-adrenergic (sympathetic) receptors...
November 16, 2023: bioRxiv
https://read.qxmd.com/read/37977486/no-additional-effect-of-a-personalized-tobacco-treatment-intervention-on-smoking-abstinence-in-individuals-eligible-for-lung-cancer-screening-brief-report-of-a-randomized-trial
#31
JOURNAL ARTICLE
Brenda Cartmel, Lisa M Fucito, Krysten W Bold, Susan Neveu, Fangyong Li, Alana M Rojewski, Ralitza Gueorguieva, Stephanie S O'Malley, Roy S Herbst, Benjamin A Toll
INTRODUCTION: To determine whether personalized gain-framed messaging and biomarker feedback related to tobacco cessation/reduction decreases smoking behavior in patients undergoing or eligible for lung cancer screening. PATIENTS AND METHODS: Between 2016 and 2020, 188 patients were enrolled in a two-phase sequential randomized controlled trial. Phase 1 examined whether standard of care (5 in-person counselling sessions and 8-weeks of nicotine patch) plus gain-framed messaging (SC+GFM) vs standard of care (SC) would increase 8-week biochemically-verified smoking cessation rates...
November 15, 2023: Journal of Thoracic Oncology
https://read.qxmd.com/read/37958488/natural-compounds-purified-from-the-leaves-of-aristotelia-chilensis-makomakinol-a-new-alkaloid-and-the-effect-of-aristoteline-and-hobartine-on-na-v-channels
#32
JOURNAL ARTICLE
Rebeca Pérez, Claudia Figueredo, Viviana Burgos, Jaime R Cabrera-Pardo, Bernd Schmidt, Matthias Heydenreich, Andreas Koch, Jennifer R Deuis, Irina Vetter, Cristian Paz
Aristotelia chilensis or "maqui" is a tree native to Chile used in the folk medicine of the Mapuche people as an anti-inflammatory agent for the treatment of digestive ailments, fever, and skin lesions. Maqui fruits are black berries which are considered a "superfruit" with notable potential health benefits, promoted to be an antioxidant, cardioprotective, and anti-inflammatory. Maqui leaves contain non-iridoid monoterpene indole alkaloids which have previously been shown to act on nicotinic acetylcholine receptors, potassium channels, and calcium channels...
October 24, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37934530/implementation-of-specialty-tobacco-use-disorder-services-in-a-community-health-setting-support-for-enhanced-prescription-practices
#33
JOURNAL ARTICLE
Lindsay R Meredith, Brian Hurley, Theodore C Friedman, Martin L Lee, Luz Rodriguez, Briana Lopez, Norma Mtume, Tasha Dixon, Hrishikesh K Belani, Susan Hsieh, Lara A Ray
OBJECTIVES: Although public efforts to reduce tobacco use have been successful, millions of US adults currently smoke tobacco. Reducing the public health burden of tobacco use disorder (TUD) and eliminating disparities experienced by underresourced communities requires increased accessibility to services. The goal of this study was to assess whether prescriptions for evidence-based medications for tobacco treatment showed steeper growth rates among community health clinics providing specialty TUD services as compared with treatment as usual...
November 2023: Journal of Addiction Medicine
https://read.qxmd.com/read/37866797/isolation-and-electrophysiological-recording-of-ixodes-ricinus-synganglion-neurons
#34
JOURNAL ARTICLE
Khalid Boussaine, Maria Taha, Cáinà Nìng, Alison Cartereau, Sabine Rakotobe, Lourdes Mateos-Hernandez, Emiliane Taillebois, Ladislav Šimo, Steeve H Thany
The central nervous system of hard ticks (Ixodidae) consists of a concentrated merged nerve mass known as the synganglion. Although knowledge of tick neurobiology has dramatically improved over the last two decades, this is the first time that isolation and electrophysiological recordings have been carried out on tick neurons from the synganglion. Method: We developed a simple protocol for synganglion neuron isolation and used a whole-cell patch clamp to measure ionic currents induced by acetylcholine, nicotine and muscarine...
October 20, 2023: Journal of Pharmacological and Toxicological Methods
https://read.qxmd.com/read/37840301/helping-pregnant-smokers-quit-a-multi-centre-randomised-controlled-trial-of-electronic-cigarettes-versus-nicotine-replacement-therapy
#35
RANDOMIZED CONTROLLED TRIAL
Dunja Przulj, Francesca Pesola, Katie Myers Smith, Hayden McRobbie, Tim Coleman, Sarah Lewis, Christopher Griffith, Robert Walton, Rachel Whitemore, Miranda Clark, Michael Ussher, Lesley Sinclair, Emily Seager, Sue Cooper, Linda Bauld, Felix Naughton, Peter Sasieni, Isaac Manyonda, Peter Hajek
BACKGROUND: Some pregnant smokers try e-cigarettes, but effectiveness and safety of such use are unknown. OBJECTIVES: To compare effectiveness and safety of nicotine patches and e-cigarettes in pregnancy. DESIGN: A pragmatic multi-centre randomised controlled trial. SETTING: Twenty-three hospitals across England, and a Stop Smoking Service in Scotland. PARTICIPANTS: One thousand one hundred and forty pregnant daily smokers (12-24 weeks' gestation) motivated to stop smoking, with no strong preference for using nicotine patches or e-cigarettes...
July 2023: Health Technology Assessment: HTA
https://read.qxmd.com/read/37821229/extracellular-atp-neurotransmission-and-nicotine-sex-specifically-modulate-habenular-neuronal-activity-in-adolescence
#36
JOURNAL ARTICLE
Yen-Chu Chen, Daniel Jun Rindner, J P Fowler, Valeria Lallai, Allison Mogul, Angelo Demuro, Gyorgy Lur, Christie D Fowler
The recent increase in the use of nicotine products by teenagers has revealed an urgent need to better understand the impact of nicotine on the adolescent brain. Here, we sought to examine the actions of extracellular adenosine triphosphate (ATP) as a neurotransmitter and to investigate whether ATP and nicotinic signaling interact during adolescence. With the GRABATP sensor, we first demonstrated that nicotine induces extracellular ATP release in the medial habenula (MHb), a brain region involved in nicotine aversion and withdrawal...
October 11, 2023: Journal of Neuroscience
https://read.qxmd.com/read/37787310/smoking-cessation-through-nicotine-replacement-therapy-for-patients-visiting-the-dental-college-pune-a-quasi-experimental-study
#37
JOURNAL ARTICLE
Ajinky Mukadam, Sahana H Shetiya
BACKGROUND AND AIM: Smoking leads to a very unhealthy lifestyle and has many deleterious effects on the body and surroundings. Studies have indicated that aiding contemplating smokers using behavior counseling and nicotine replacement therapy has shown positive results for abstaining from the habit. We aimed to assess and carry out smoking cessation for smokers using behavioral counseling, motivational interviewing, and nicotine replacement therapy (NRT) and assess their carbon monoxide (CO) cutoff level, Fagerstrom nicotine dependence test (FTND) scoring, and transtheoretical model (TTM) of change at baseline and 6 months, along with abstinence from the habit...
2023: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/37753382/effectiveness-of-a-media-campaign-promoting-health-care-provider-tobacco-dependence-treatment
#38
JOURNAL ARTICLE
Kim A Hayes, Elizabeth M Brown, James Nonnemaker, Harlan Juster, Christina Ortega-Peluso, Matthew C Farrelly, Kevin Davis
The New York State Department of Health (NYSDOH) developed a provider-focused media campaign to encourage provision of evidence-based, clinical tobacco dependence treatment (TDT). The purpose of this study was to assess providers' awareness of the campaign and the relationship between campaign awareness and changes in campaign-related beliefs and clinical TDT intervention. We conducted a longitudinal, mailed survey of health care providers in New York State (n = 851; AAPOR3 RR: 24.6%). We estimated descriptive statistics and used multivariable regression analyses to assess whether changes in key outcomes (campaign-related beliefs and clinical TDT) from pre- to post-campaign vary by self-reported campaign awareness...
December 2023: Preventive Medicine Reports
https://read.qxmd.com/read/37725265/quitline-usage-does-not-improve-rates-of-smoking-cessation-in-orthopaedic-trauma-patients-unless-combined-with-nicotine-replacement-therapy
#39
JOURNAL ARTICLE
Paul E Matuszewski, Tyler Pease, Jalen A Martin, Katherine Joseph, Robert V O'Toole
PURPOSE: The negative effects of smoking following traumatic orthopaedic injury can lead to serious complications and decreased quality of life. The widely available quitline could be easily implemented in the orthopaedic postoperative period to improve outcome, but the effectiveness of this intervention in this population is unknown. The goal of this study was to determine if active referral to a quitline would improve rates of smoking cessation in this population. METHODS: This is a secondary analysis of a randomized control trial assessing the effectiveness of an inpatient intervention with varying intensities to promote smoking cessation...
September 19, 2023: European Journal of Orthopaedic Surgery & Traumatology: Orthopédie Traumatologie
https://read.qxmd.com/read/37696529/pharmacological-and-electronic-cigarette-interventions-for-smoking-cessation-in-adults-component-network-meta-analyses
#40
REVIEW
Nicola Lindson, Annika Theodoulou, José M Ordóñez-Mena, Thomas R Fanshawe, Alex J Sutton, Jonathan Livingstone-Banks, Anisa Hajizadeh, Sufen Zhu, Paul Aveyard, Suzanne C Freeman, Sanjay Agrawal, Jamie Hartmann-Boyce
BACKGROUND: Tobacco smoking is the leading preventable cause of death and disease worldwide. Stopping smoking can reduce this harm and many people would like to stop. There are a number of medicines licenced to help people quit globally, and e-cigarettes are used for this purpose in many countries. Typically treatments work by reducing cravings to smoke, thus aiding initial abstinence and preventing relapse. More information on comparative effects of these treatments is needed to inform treatment decisions and policies...
September 12, 2023: Cochrane Database of Systematic Reviews
keyword
keyword
103941
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.